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 The characteristic pattern of expression on macro-
phages and a robust ex vivo affi nity for oxidized low-den-
sity lipoproteins (Ox-LDL) ( 10 ) led to the classifi cation of 
CD68 as a group D scavenger receptor ( 4, 11 ). Consistent 
with its classifi cation as a LAMP-1 family member, CD68 
was found to predominately localize to late endosomal 
and lysosomal compartments with a modest level of cell 
surface expression ( 12 ). Its short cytoplasmic tail, ability to 
rapidly traffi c from cell surface to endosomes, and its in-
trinsic ability to bind Ox-LDL and phosphatidylserine, 
were often cited as evidence that CD68 served as a scaven-
ger receptor ( 3, 10, 12, 13 ). 
 Although initially characterized for their ability to direct 
lipid and apoptotic cell uptake, the ability of scavenger re-
ceptors (ScRs) to recognize polyanionic ligands has also 
afforded them an important role in the nonopsonic phago-
cytosis of numerous microbes ( 1, 4 ). Consistent with this, 
a number of single and double murine ScR knockouts 
(ko) have validated their roles in these seemingly dispa-
rate infl ammatory processes ( 1, 4 ). Although CD68 shares 
a number of these features, more recent studies have 
called into question its role in the recognition and uptake 
of Ox-LDL ( 14 ). Rather, they raised the possibility that 
CD68 may regulate the response to ligands after internal-
ization. To more carefully explore the potential role CD68 
plays in the ability of macrophages to either take up or di-
rect an innate response to Ox-LDL and microbial ligands, 
knockout mice were generated. Analysis of CD68   /   
mononuclear phagocytes failed to support an important 
 Abstract  Scavenger receptors (ScRs) are a structurally un-
related family of receptors with the ability to bind modifi ed 
low density lipoprotein (LDL) as well as a broad range of 
polyanionic ligands. CD68, whose expression is restricted to 
mononuclear phagocytes, is a unique ScR family member, 
owing to its lysosome associated membrane protein (LAMP)-
like domain and predominant endosomal distribution. 
Knockout (ko) mice were generated to directly evaluate the 
role murine CD68 may play in oxidized LDL (Ox-LDL) up-
take. However, CD68   /   macrophages took up Ox-LDL ro-
bustly. Likewise, no defects were observed in the ability of 
CD68   /   mononuclear phagocytes to take up or mount an 
effective innate response against a number of microbes.  
Curiously, CD68   /   mononuclear phagocytes exhibited a 
trend toward enhanced antigen presentation to CD4+ T-
cells, raising the possibility that CD68 may function either to 
negatively regulate antigen uptake, loading, or major histo-
compatibility complex class II (MHC-II) traffi cking. —Song, 
L., C. Lee, and C. Schindler. Deletion of the murine scaven-
ger receptor CD68.  J. Lipid Res. 2011.  52: 1542–1550. 
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 CD68 and its murine homolog, macrosialin, is a highly 
glycosylated,   95-110 kDa member of the lysosome-associ-
ated membrane protein (LAMP)-1 family, which is widely 
expressed on mononuclear phagocytes ( 1–3 ). It was ini-
tially identifi ed as the antigen recognized by monoclonal 
antibodies directed against human and murine mac-
rophage epitopes ( 2, 3 ). Immunohistochemical studies 
revealed that CD68 expression was largely restricted to 
monocytes and tissue-specifi c macrophages, notably in-
cluding those in the peritoneum, lungs, spleen, and liver, 
as well as Langerhans cells and microglia ( 1, 4 ). Moreover, 
expression appeared to correlate with macrophage activa-
tion ( 5, 6 ). Consistent with these observations, the CD68 
promoter has been exploited successfully to direct the ex-
pression of transgenes toward the macrophage lineage in 
vivo ( 7–9 ). 
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CD68 knockout 1543
dendritic cells (DC) were recovered (  75% CD11c + ) and re-
plated for an additional two or three days prior to analysis. Phagocytic 
activity was measured by incubating macrophages with either 
heat-killed FITC-labeled  S. aureus as previously described ( 21 ); or 
LDL (Intracel Resources, Frederick, MD) that had been moder-
ately oxidized with 40   M CuSO 4 as previously reported ( 22 ). 
Lipid uptake was measured by fl ow cytometry of live cells by gating 
on DiI (1,1 ′ -dioetadeeyl-3,3,3 ′ ,3 ′ -tetramethylindocarboeyanine 
perchlorate; Sigma-Aldrich, St. Louis, MO) labeled Ox-LDL, or 
in fi xed PECs by staining with oil red O, as previously reported 
( 22, 23 ). PECs were also stained with antibodies specifi c for CD68 
(1:100, 2 h; MAC1957, FA11; Serotec, Oxford, UK) and LAMP-1 
(Southern Biotech, Birmingham, AL) after samples had been 
fi xed (4% paraformaldehyde, methanol; 20 min) and blocked 
(2% goat serum) as previously reported ( 24, 25 ). Antibodies were 
detected with anti-rat IgG-FITC (1:100, 1 h; STAR69, Serotec) or 
anti-rat IgG-Cy3 (1:500, 1 h; Jackson ImmunoResearch, West 
Grove, PA) or anti-rat IgG-HRP (Vector Labs, Burlingame, CA) 
and visualized with a DAB substrate kit from Vectastain (Vector 
Labs) ( 23 ). Images were captured with a Nikon Eclipse TE300 
microscope on a Spot camera (Sterling Heights, MI) and ana-
lyzed with OpenLabs (Waltham, MA) software. 
 Microbicidal activity 
 The ability of macrophages to generate nitric oxide (NO) in 
response to treatment with lipopolysaccharide (LPS) (100 ng/ml; 
from  E. coli serotype 055:B5; Sigma-Aldrich, St. Louis, MO) and/or 
IFN-  (50 U/ml; murine; PBL, Piscataway, NJ) was carried out as 
previously reported ( 24 ). Growth of  Legionella pneumophila , a fac-
ultative intracellular bacterium, was evaluated by infecting BMMs 
(0.5 × 10 6 per well in a 12-well plate, in triplicate) with 3,000 col-
ony-forming units (CFU) of postlogarithmic growth bacteria, as 
recently reported ( 26 ). The capacity of macrophages to promote 
viral growth was evaluated by infecting BMMs with vesicular stoma-
titis virus (VSV; Indiana strain) at multiple multiplicities of infec-
tions (MOI) and titering the supernatant for plaque-forming 
units (PFU) on Vero cells, as previously reported ( 24 ). 
 Flow cytometry 
 Fluorescence activated cell sorting (FACS) analysis was carried 
out on cells harvested from euthanized mice. Broncho-alveolar 
lavage (BAL) fl uid was recovered in three sequential 1 ml (PBS) 
lung lavages, as reported ( 27, 28 ). Bone marrow (BM) and peri-
toneal macrophages were prepared as described above. Additional 
leukocytes were harvested from femurs (BM cells) and spleen 
(splenocytes), or blood. Single-cell suspensions were RBC-de-
pleted (Sigma), resuspended in RPMI 1640/10% FCS, and then 
counted and/or stained for FACS. Adherent cells (BMMs) were 
treated for 5 min with trypsin/EDTA (Sigma-Aldrich), whereas 
BMDCs were collected by gentle pipetting prior to staining for 
FACS. Cells were stained with anti-CD11b (M1/70), F4/80 
(BM8), Gr-1 (RB6-8C5), CD8a (53-6.7), CD206 (48-2069) from 
eBioscience (San Diego, CA) or anti-CD11c (HL3), CD3e (145-
2C11), CD4 (RM4-5), I-Ab (MHC-II; AF6-120.1), CD86 (GL1), 
NK1.1 (PK136) from BD Pharmingen (San Diego, CA) or anti-
CD68 (MAC1957; FA11) and CD206 (MR5D3) from Serotec 
(Oxford, UK), after treatment with Fc-blocker (anti-CD16/CD32, 
2.4G2; BD-Pharmingen). Cells were fi xed and stained with CD68 
antibodies as per manufacturer (Serotec). Data were acquired on 
a FACS Calibur or FACS LSR-II (Beckton Dickinson, Franklin Lakes, 
NJ) and analyzed by FlowJo software (TreeStar, Ashland, OR). 
 Cytokine profi ling 
 Cultured macrophages or DCs were treated with LPS (100 or 
1,000 ng/ml; Sigma), IFN-  (50 U/ml; murine; PBL, Piscataway, 
role in the uptake of either Ox-LDL, microbes, or an asso-
ciated infl ammatory response. However, the enhanced ca-
pacity of these knockout cells to present antigen to CD4 + 
T-cells raises the possibility that CD68 may negatively regu-
late major histocompatibility complex class II (MHC-II) 
activity. 
 MATERIALS AND METHODS 
 Gene targeting 
 CD68 gene targeting vector was generated by PCR amplifi ca-
tion (Expanded Long Template PCR System; Roche, Indianapo-
lis, IN) of a 1.6 kb short arm and 6.5 kb long arm from C57Bl6/J 
mice genomic DNA, as illustrated in  Fig. 2 , with primers: 5 ′ T GC 
GGC CGC CCC TAT GCT GAA ACC CAA GTG TTC C 3 ′ and 5 ′ 
C TC TAG ACA TAT G AG AGA TGC TCA GAC CAG CTA GGC 
3 ′ for the short arm and 5 ′  CTC GAG CGG CTC CCT GTG TGT 
CTG ATC TTG C 3 ′ and 5 ′  GCG  GCC GC A GGA CAG GGG CTA 
CAC AGA AAC CC 3 ′ for the long arm (Not I, Xba I, Nde I, Xho 
I, and Not I endonuclease restriction sites are underlined and 
were included for cloning; New England Biolab, MA). A loxP-
fl anked neomycin cassette was amplifi ed from pMC1neo Poly A 
plasmid (Stratagene, San Diego, CA) with primers: 5 ′  CTC GAG 
ATA ACT TCG TAT AGC ATA CAT TAT ACG AAG TTA TGA 
ACA AAC GAC CCA ACA CCC GTG C 3 ′ and 5 ′  GTC GAC ATA 
ACT TCG TAT AAT GTA TGC TAT ACG AAG TTA TGC AGT 
GTG GTT TTG CAA GAG GAA GC 3 ′ (Xho I and Sal I enoducle-
ase restriction sites are underlined) and cloned, inverted, down-
stream from an rtTA cassette ( 15 ). This unit was then cloned 
immediately downstream and in frame with the CD68 initiation 
ATG located at the 3 ′ end of the short arm. The targeting con-
struct was assembled in a vector provided by Dr. V. Lin that fea-
tures a negative selectable diphtheria toxin (DT) gene ( 16 ). The 
integrity of the targeting construct was confi rmed by sequencing 
prior to electroporation into 129 R1 ES cells ( 17 ). Neomycin re-
sistant clones were evaluated by Southern blotting with a probe 
localized to the 5 ′ end of the short arm (see  Fig. 2 ). Properly 
targeted CD68 knockout ES cells (2 of 192 neomycin-positive 
clones) were introduced into blastocyts to generate chimeric 
mice, as previously reported ( 18 ). Chimeric mice were either 
crossed with 129 mice or backcrossed seven generations to the 
C57Bl/6J background. Transmission of the knockout allele was 
determined by Southern blot and PCR. Columbia University re-
view committees approved all relevant studies. 
 Cell culture 
 Resident peritoneal macrophages were harvested by lavage 
with 10 ml RPMI 1640 (Invitrogen-GIBCO, Grand Island, NY) 
supplemented with 10% FCS (Hyclone, Logan, UT) from freshly 
euthanized mice. Recovered cells were plated (1 × 10 6 cells/ml), 
and nonadherent cells were removed after 2 h by aspiration. Peri-
toneal-elicited cells (PEC; i.e., macrophages) were recovered by 
the same procedure four days after instillation of 1 ml of 4% thio-
glycollate (DIFCO; Voigt Global Dist., Inc, Lawrence, KS). Bone 
marrow-derived macrophages (BMMs) were prepared in RPMI 
1640 supplemented with 10% FCS, penicillin/streptomycin 
(GIBCO), and 20% L-cell conditioned media, as previously re-
ported ( 19 ). Bone marrow-derived dendritic cells (BMDC) were 
prepared similarly, except that they were grown in RPMI 1640 
supplemented with a 1/30 dilution of GM-CSF conditioned me-
dia (from J558 cells), 5% FCS, pen/strep, and   -mercaptoethenol 
(GIBCO), as previously described ( 20 ). Cells were fed gently with 
fresh media on days 3 and 5. On day 7, loosely adherent clustering 
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 To explore the potential role CD68 plays in ligand up-
take, its gene was targeted for deletion by a recombination 
vector featuring two homology arms and a neomycin cas-
sette (see  Fig. 2 ). Chimeric mice with a targeted allele were 
then either crossed with 129 or C57Bl/6 mice and then 
NJ), interleukin (IL)-4 (10 ng/ml; Peprotech, Rocky Hill, NJ), 
zymosan (100 µg/ml; Sigma) or silicates (0.4 mg/ml; see below). 
Supernatants were collected after 24 h and evaluated by ELISA 
for tumor necrosis factor (TNF)-  and IL-6 production (eBiosci-
ence) or IL-1  production (Pierce, Rockford, IL). Quartz (Min-
U-Sil 5) was a gift from US Silica (Berkeley Springs, WV) and 
featured >98% purity, an average size of 1.83 µm (range 1.70-1.89 
µm), and no amorphous coating ( 29, 30 ). Tridymite (99% pu-
rity, 0.5-1 µm, no amorphous coating) was a generous gift from B. 
Pernis ( 31, 32 ). Silicates, which were baked at 250°C for 16 h 
prior to suspension in PBS, were sonicated prior to stimulation 
and negative for endotoxin contamination (Limulus assay; Cam-
brex Bio Science, Walkersville, MD). 
 T-cell analysis 
 An amount of 3 × 10 5 ovalbumin (OVA)-specifi c CD4 + T-cells 
(anti-CD4 MACS beads; Miltenyi Biotech, Auburn, CA) from 
OT-II TCR transgenic spleens were cultured for four days with 
3 × 10 4 BMDCs, which had previously been loaded for 4 h with 
increasing concentrations of OVA (Worthington Biochemical 
Corporation, Lakewood, NJ) or OVA peptide 326-332 (New Eng-
land Peptide, Inc., Gardner, MA). T-cell proliferation was mea-
sured by  3 H-thymidine incorporation (14 h, 37°C; Perkin Elmer 
Life Sciences, Shelton, CT), as previously reported ( 20 ). 
 PCR 
 DNA or RNA was recovered from FACS-purifi ed leukocyte 
populations with Trizol (Invitrogen). RNA was reverse tran-
scribed with SuperScript™ II (Invitrogen), as previously reported 
( 19, 24 ). DNA and cDNA were either PCR amplifi ed by standard 
or quantitative methods (ABI Prism 7700 with SYBR green mas-
ter mix; Applied Biosystems, Foster City, CA). Gene expression 
was normalized to a   -actin or 18S rRNA control. Ct values and 
standard curves were generated by plotting log of DNA concen-
tration versus Ct values from 1:5 serial dilutions with SDS1.9.1 
software (Applied Biosystems). Primers were annealed at 60  C 
and run 40 cycles. Primers sets included: Arginase-1 (forward) 5 ′ 
aga cca cag tct ggc agt tg, (reverse) 5 ′ cca ccc aaa tga cac ata gg; 
18S (forward) 5 ′ tca aga acg aaa gtc gga gg 3 ′ , (reverse) 5 ′ gga cat 
cta agg gca tca ca 3 ′ ; eif4a1 (forward) 5 ′ gga agg cgt cat cga gag 
taa ctg, (reverse) 5 ′ ccc aat gca ggc atg aca aag agg; mupd.1 (for-
ward) 5 ′ gcg ctg ttc ctg aca ctc cag acc, (reverse) 5 ′ cca gta gaa gag 
gac ctg ggc agc. 
 RESULTS 
 Characterization and deletion of CD68 
 Although predominately restricted to endosomes, CD68 
expression has been largely associated with myeloid cells 
from the macrophage lineage ( 1 ). Consistent with previ-
ous reports, CD68 staining was strongest after membrane 
permeablization, and it was largely localized to LAMP1-
positive vesicles (supplementary Fig. I) ( 1 ). When primary 
murine myeloid cells were evaluated, strong CD68 expres-
sion was observed in several macrophage lineages, includ-
ing alveolar, splenic, BM, and peritoneal macrophages, as 
well as BM culture-derived macrophages (see  Fig. 1 ) ( 1, 
33 ).  Likewise, robust CD68 expression was observed in sev-
eral DC populations, including pulmonary- and splenic-
CD8  + DCs and BM culture-derived DCs, but not in 
CD8  −  DCs ( Fig. 1 ). As anticipated, CD68 was not detected 
on B220 + or CD3 + lymphocytes (not shown). 
 Fig.  1. CD68 expression in murine mononuclear phagocytes. 
Primary, as well as BM-derived, macrophages and DCs were stained 
for specifi c cell surface markers and CD68, and then evaluated by 
FACS. CD68 expression was high in BAL DCs (CD11b + /CD11c + 
versus CD11b + /CD11c    in gray) and M  s (CD11b    /CD11c ++ ver-
sus CD11b    /CD11c    in gray). CD68 expression was also robust in 
splenic M  s (CD11b + /F4/80 + versus CD11b    /F4/80    in gray) and 
lymphoid DCs (CD11c + /MHC-II + /CD8  + versus CD11c + /MHC-
II + /CD8     in gray). Likewise, CD68 expression was strong in M  s 
recovered from BM (CD11b + /F4/80 + versus unstained in gray), as 
well as resident (CD11b + /F4/80 + in gray) and thioglycollate-elic-
ited (CD11b + /F4/80 + black line) M  s. Finally, CD68 expression 
was also elevated in BM-derived M  s (CD11b + versus unstained in 
gray) and BM-derived DCs (CD8 + /CD11c + versus unstained in 
gray). 
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interbred to homozygosity. Progeny CD68 knockout 
(CD68   /   ) mice developed with normal Mendelian ge-
netics in both backgrounds (e.g.,  Fig. 2B ; data not shown); 
they exhibited no obvious phenotypes, including no evi-
dence of organomegally and no signifi cant perturbations 
of defi ned leukocyte populations in either the blood or 
spleen ( Tables 1 and 2 ; supplementary Fig. II).  Western 
blotting, immunohistochemical studies, and FACS analysis 
confi rmed an absence of CD68 expression in macrophages 
from CD68 knockout mice ( Fig. 2C–E ). CD68 +/   (i.e., 
heterozygous) mice exhibited a corresponding partial de-
crease in CD68 expression ( Fig. 2C ). Given the relatively 
high density of genes at the CD68 locus, it was important 
to confi rm that the expression of both  eif4a1 and  mpdu.1 
 Fig.  2. Generation of CD68 knockout mice. (A) Three models describe:  i ) the endogenous  cd68 locus, which lies in a gene-rich cluster - 
 eif4a1 (eukaryote initiation factor 4A1) abuts the promoter and  mpdu.1 (Mannose-P-dolichol utilization defect 1) lies downstream;  ii ) the 
cd68 gene-targeting vector featuring a 1.6 kb 5 ′ homology arm, a Neo cassette, a 6.5 kb 3 ′ homology arm, and the DT gene; and  iii ) the 
targeted locus. Exons are illustrated as rectangles (dark = coding; white = noncoding). Hind III (H) restriction sites and the CD68 initiation 
codon (ATG) are indicated. Neomycin resistance (Neo) (including loxP sites and rtTA; not shown) and DT gene cassettes are depicted as 
gray rectangles. 5 ′ “outside” probe used for Southern blots lies in  eif4a1 , as shown. (B) Southern blotting analysis of progeny from a het +/   
intercross. Tail DNA was digested with Hind III and analyzed with the 5 ′ probe. The wt +/+ and targeted (ko)   /   bands are marked. 
(C) Western blot of whole-cell extracts from PECs. Whole-cell extracts from wt, heterozygous (het) and ko PECs were loaded, or not, with 
Ox-LDL (100 µg/ml, 16 h), fractionated by SDS-PAGE, and immunoblotted with an antibody specifi c for CD68 (FA11; Serotec). The fi lter 
was reprobed for Stat2 as a loading control. (D) Immunohistochemical stain of wt and ko PECs from panel C stained for CD68 (brown 
color) at 10× (upper panels) and 60× (lower panels) magnifi cation. Cells are counterstained with hematoxylin (blue). (E) FACS analysis 
for CD68 expression of wt and ko splenic macrophages and PECs, as in  Fig. 1 . 
(upstream and downstream fl anking genes; see  Fig. 2 ) was 
not affected by the introduction of a neomycin cassette 
into the CD68 locus (supplementary Fig. III). In summary, 
these studies revealed that homozygous deletion of the 
CD68 gene was not associated with any signifi cant develop-
mental or homeostatic defects. 
 CD68   /   macrophages exhibit normal scavenger receptor 
activity 
 Shortly after its initial characterization ( 3, 34 ), CD68 was 
identifi ed as a 94-97 kDa receptor for Ox-LDL, adding it to 
the growing family of scavenger receptors ( 1, 4 ). Despite its 
largely intracellular distribution, dynamic studies suggested 
CD68 exhibited a robust capacity to rapidly transport 
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( 26, 36 ). More importantly, wt and CD68   /   macrophages 
supported equivalent levels of growth, suggesting CD68 
does not signifi cantly contribute to the innate response 
toward these intracellular pathogens. Similarly, CD68   /   
macrophages and mice both failed to exhibit a defective 
innate response upon infection with  Listeria monocytogenes , 
another intracellular bacterial pathogen (data not shown). 
Next, the capacity of CD68   /   macrophages to support 
the growth of vesicular stomatitis virus was evaluated. 
Again, there were no signifi cant differences in VSV repli-
cation in either wt or CD68   /   macrophages. This was true 
Ox-LDL as well as other ligands into the endosomal compart-
ment ( 12 ). Subsequent RNAi knockdown studies, however, 
failed to confi rm a signifi cant role for CD68 in Ox-LDL 
uptake ( 14 ). To more rigorously explore the capacity of 
CD68 to serve as a scavenger receptor, primary peritoneal 
macrophages were harvested from knockout mice and in-
cubated with increasing concentrations of Ox-LDL. Both 
wild-type and knockout macrophages took up Ox-LDL in a 
dose-dependent manner ( Fig. 3A , B ;  supplementary 
Fig. IV). Intriguingly, CD68   /   macrophages even exhib-
ited a trend toward enhanced Ox-LDL uptake at lower 
doses. Next, the more general phagocytic activity of CD68 
knockout macrophages was evaluated by incubating cells 
with fl uorescently-labeled, heat-killed  Staphylococcus aureus . 
Again, CD68   /   macrophages exhibited a dose-dependent 
uptake of bacteria that paralleled the pattern observed in 
wild-type macrophages ( Fig. 3B , top panels). Moreover, 
CD68   /   macrophages exhibited no signifi cant differences 
in either the binding (i.e., 4°C) or uptake (i.e., 37°C) of 
opsonized, labeled, heat-killed  S. aureus ( Fig. 3B , bottom 
panels), suggesting that CD68 does not play an important 
role in either Ox-LDL or bacteria uptake by macrophages. 
 Innate immune response in CD68   /   macrophages 
 Since CD68 is predominately localized to the endosomal 
compartment, its capacity to contribute to the innate in-
tracellular response to microbial pathogens was explored. 
First, the capacity to generate NO, an important antibacte-
rial effector, was evaluated ( 35 ). As shown in  Fig. 4A ,  both 
wild-type (wt) and CD68   /   macrophages produced equiv-
alent quantities of NO in response to stimulation with 
IFN-  and LPS. Next, the capacity of CD68 to affect the 
innate response to microbial infection was evaluated. Con-
sistent with previous studies on the innate response, when 
murine macrophages were infected with  L. pneumophila , 
they replicated modestly over a four-day period ( Fig. 4B ) 
 TABLE 1. Leukocyte subtypes in CD68   /   blood 
B220 + CD3 + CD11b + ; Gr-1 hi CD11b + ; Gr-1 lo CD11b    ; Gr-1 + 
wt 44.9 ± 3.9 27.2 ± 3.9 4.4 ± 2.3 6.8 ± 0.4 2.3 ± 0.1
het 41.4 ± 3.8 26.8 ± 4.8 3.9 ± 0.6 7.5 ± 0.6 2.2 ± 0.1
ko 44.1 ± 5.5 20.4 ± 1.7 8.1 ± 3.2 6.3 ± 0.8 2.4 ± 0.5
Peripheral blood from three-month-old matched wild-type (wt), 
heterozygous (het), and CD68   /   (ko) mice that were backcrossed to 
C57Bl/6J mice six times, was stained for B220 (B lymphocytes), CD3 (T 
lymphocytes), CD11b (macrophages), and Gr-1 (granulocytes/monocytes)
and analyzed by FACS. Mean and standard deviation of the percentage 
of positive cells are shown.
 TABLE 2. Leukocyte distribution in CD68   /   spleen 
B220 + CD3 + CD11b + CD11c + 
wt 61.1 ± 1.7 25.1 ± 3.2 4.3 ± 3.9 2.3 ± 1.8
het 58.3 ± 5.0 25.4 ± 2.4 4.3 ± 2.3 2.4 ± 1.0
ko 59.8 ± 1.7 25.5 ± 2.7 3.8 ± 1.2 1.8 ± 0.7
Splenocytes from three-month-old matched wild-type (wt), 
heterozygous (het), and CD68   /   (ko) mice (as in  Table 1 ) were 
stained for B220 (B lymphocytes), CD3 (T lymphocytes), CD11b 
(macrophages), and CD11c (dendritic cells) and analyzed by FACS. 
Mean and standard deviation of the percentage of positive cells are 
shown.
 Fig.  3. CD68 knockout macrophages exhibit robust phagocytic 
activity. (A) wt and CD68 ko PECs were loaded with increasing 
doses of DiI-labeled Ox-LDL (0.1, 1.0, and 10 µg/ml, 4 h, 37°C) as 
indicated. Lipid uptake was measured by FACS and graphed as 
mean fl uorescence intensity (MFI). (B) In the top panels, wt and 
ko PECs were incubated with increasing MOIs (10 - dotted gray 
lines; 100 - dotted black lines; 1000 - solid black lines) of FITC-la-
beled, heat-killed  Staphylococcus aureus for 4 h, and then evaluated 
by FACS. Extracellular fl uorescence was quenched with trypan 
blue. Histogram of maximal fl uorescence reveals an equivalent, 
dose-dependent bacterial uptake by wt and ko PECs. Untreated 
cells are shown in gray. The bottom panels demonstrate that after 
30 min, opsonized (mouse serum) FITC -S. aureus (MOI = 10) are 
both bound (i.e., 4°C) and taken up (37°C) equivalently in wt (dot-
ted gray lines) and ko (solid black lines) PECs. 
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phenotype, which is characterized by CD206, arginase 
1, and IL-10 expression (supplementary Fig. V) ( 39 ). 
 Next, we examined the ability of CD68   /   macrophages 
to respond to silica crystals (e.g., quartz), which have re-
cently been shown to robustly stimulate IL-1  secretion 
through activation of the infl ammasome ( 30, 32, 38 ). 
Wild-type and CD68   /   peritoneal macrophages were 
stimulated with two forms of highly purifi ed, endotoxin-
free crystalline silica, tridymite, and quartz. Again, the re-
sponse of CD68   /   macrophages was equivalent to wt 
macrophages ( Fig. 5B ). Additional studies confi rmed that 
these responses were sensitive to cytochalasin D (data not 
shown), suggesting these crystals must enter the cell to be 
sensed ( 30, 38 ). In summary, these studies revealed that 
CD68 does not signifi cantly contribute to the innate re-
sponse to a divergent set of infl ammatory stimulants. 
 Adaptive immunity in CD68   /   mononuclear phagocytes 
 Having excluded an important role for CD68 in either 
the uptake or infl ammatory responses associated with in-
nate immunity, the possibility that CD68 might play a role 
in adaptive immunity was explored. Because of their po-
tent capacity to present antigens, these studies focused on 
at both low MOIs, which feature a more robust innate re-
sponse, and at the higher MOIs favoring more robust viral 
growth ( Fig. 4C ). 
 The infl ammatory response of CD68   /   mononuclear 
phagocytes 
 In addition to their phagocytic capacity, mononuclear 
phagocytes feature a number of innate immune recep-
tors that detect pathogen-associated molecular patterns 
(PAMP; e.g., LPS and zymosan) ( 37 ) and danger-associ-
ated molecular patterns (DAMP; e.g., silica) ( 30, 38 ), 
which direct the secretion of potent infl ammatory cy-
tokines (e.g., TNF-  , IL-1  , and IL-6). To examine 
whether CD68 might contribute to this response, 
CD68   /   macrophages and DCs were stimulated with a 
few PAMPs and DAMPs. No differences were observed 
in the capacity of either LPS or Zymosan to stimulate 
TNF-  or IL-6 production in either wild-type or CD68   /   
macrophages or DCs ( Fig. 5A ).  Moreover, the robust in-
fl ammatory response of CD68   /   macrophages to LPS 
( Fig. 5A ) and IFN-  (data not shown) indicated that 
CD68 does not play a signifi cant role in the response of 
classically activated M1 macrophages. Likewise, no dif-
ferences were observed in the ability of CD68   /   mac-
rophages to be polarized to the M2 noninfl ammatory 
 Fig.  4. CD68 knockout macrophages exhibit a normal response 
to microbial infection. (A) IFN-  (50 U/m, 48 h) and LPS (100 
ng/ml, 48 h) stimulated equivalent levels of NO production in wt 
and ko PECs. (B) wt and ko BMMs yielded equivalent levels of  L. 
pneumophila growth (CFUs) over four days ( 26 ). (C) wt and ko 
BMMs yielded equivalent levels of VSV (PFUs) at several MOIs (0.1, 
1.0, and 10; 48 h). 
 Fig.  5. CD68 knockout mononuclear phagocytes exhibit a nor-
mal infl ammatory response. (A) Control (Cntl; wt and het) and ko 
BMDCs (day 9) and BMMs produce equivalent levels of TNF-  and 
IL-6 after 16 h of stimulation with LPS (100 ng/ml) or Zymosan 
(Zymo; 100 µg/ml). Stimulation with IL-4 (10 ng/ml) and thiogly-
collate (Thio; 2 mg/ml) served as negative controls. (B) Control 
(Cntl; wt and het) and ko PECs produce equivalent levels of TNF-  
and IL-1  after 16 h stimulation with Tridymite (Trid; 0.4 mg/ml) 
or Quartz (0.4 mg/ml). 
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DCs. First, PAMP-dependent upregulation of MHC-II and 
coreceptors was examined. These studies highlighted a 
modest increase in basal MHC-II, but not CD86, surface 
expression in CD68   /   BMDCs ( Fig. 6A ).  However, the 
robust, LPS-dependent induction of MHC-II was essen-
tially equivalent in wt and CD68   /   DCs. CD86 upregula-
tion was modestly enhanced in CD68   /   DCs. 
 Next, DCs were loaded with increasing doses of OVA 
to evaluate their ability to present antigen to OVA-MHC-
II-specifi c OT-II T-cells. At lower, nonsaturating concen-
trations of OVA, wt and CD68   /   DCs were equivalent in 
their capacity to stimulate proliferation of naïve OT-II T-
cells ( Fig. 6B ). Yet at higher, but not the highest, concen-
tration of OVA (i.e., 0.05 and 0.1 mg/ml;  Fig. 6B ) 
CD68   /   DCs exhibited increased ability to stimulate T-
cell proliferation. Similarly, CD68   /   DCs loaded with a 
specifi c OT-II-activating OVA peptide stimulated more 
robust T-cell proliferation at higher doses ( Fig. 6B ). 
These observations raised the possibility that CD68 may 
negatively regulate the capacity of DCs to present anti-
gen to naïve T-cells, especially under conditions of high 
antigen load. 
 DISCUSSION 
 CD68 is a member of the ScR family that has been widely 
exploited as a macrophage marker (reviewed in Refs.  1, 
4, and  11 ). However, consistent with its conserved “extra-
cellular” LAMP domain, CD68 predominately localizes to 
LAMP-1-positive intracellular vesicles. Expression is up-
regulated in response to various infl ammatory stimuli, in-
cluding oxidized LDL. Yet, despite robust binding activity, 
CD68’s role in either the endocytosis or processing of oxi-
dized LDL remains controversial ( 3, 10, 12–14 ). To more 
rigorously evaluate the role of this conserved member of 
the LAMP-1 family in infl ammatory responses, CD68 
knockout mice were generated. Initial characterization of 
tissues from CD68   /   mice underscored a loss of expres-
sion in both macrophage and DC populations that nor-
mally express CD68. Moreover, this was not associated with 
a perturbation in either the number or distribution of any 
leukocyte populations recovered from the blood, spleen, 
peritoneum, lung, or lymph nodes. 
 With a robust affi nity for Ox-LDL and phosphatidylser-
ine, initial studies had implicated CD68 in modifi ed lipid 
uptake ( 12, 40 ). However, subsequent ectopic overexpres-
sion and partial knockdown studies failed to support an 
important role for CD68 in Ox-LDL uptake ( 14 ). Consis-
tent with these observations, CD68   /   peritoneal mac-
rophages ( Fig. 3 ; supplementary Fig. IV) and BMMs (data 
not shown) failed to exhibit any defect in Ox-LDL uptake. 
Rather, several experiments revealed a trend toward en-
hanced lipid uptake in CD68   /   macrophages. 
 Having excluded an important role in Ox-LDL uptake, 
it was important to determine whether CD68 might direct 
the uptake of bacteria, a property associated with other 
ScRs. However, CD68   /   macrophages were fully able to 
bind and phagocytose both nonopsonized and opsonized 
 Fig.  6. CD68 knockout DCs exhibit enhanced antigen present-
ing activity. (A) LPS (100 ng/ml, 24 h) stimulated CD86 and MHC-
II expression was evaluated in wt and ko BMDCs (day 9) by FACS. 
(B) OT-II T-cells were either stimulated with ovalbumin (OVA; 
0.001-1.0 mg/ml, 4 h; top panel) or OVA-peptide (OVAp; 0.001-1.0 
mM, 4 h; bottom panel) loaded wt and ko BMDCs (day 6). T-cell 
proliferation was measured by  3 H-Tdr incorporation, as previously 
reported ( 20 ).  P values were 0.0019 for 0.01 mg/ml OVA, 0.0425 
for 0.05 mg/ml OVA, 0.00196 for 0.1 mg/ml of OVA, 0.0946 for 0.1 
mM OVAp, and 0.0451 for 1 mM OVAp. 
 by guest, on Novem
ber 21, 2017
w
w
w
.jlr.org
D
ow
nloaded from
 
.html 
http://www.jlr.org/content/suppl/2011/05/13/jlr.M015412.DC1
Supplemental Material can be found at:
CD68 knockout 1549
  3 .  Holness ,  C. L. ,  R. P.  da Silva ,  J.  Fawcett ,  S.  Gordon , and  D. L. 
 Simmons .  1993 .  Macrosialin, a mouse macrophage-restricted gly-
coprotein, is a member of the lamp/lgp family.  J. Biol. Chem.  268 : 
 9661 – 9666 . 
  4 .  Moore ,  K. J. , and  M. W.  Freeman .  2006 .  Scavenger receptors in 
atherosclerosis: beyond lipid uptake.  Arterioscler. Thromb. Vasc. Biol. 
 26 :  1702 – 1711 . 
  5 .  da Silva ,  R. P. , and  S.  Gordon .  1999 .  Phagocytosis stimulates alter-
native glycosylation of macrosialin (mouse CD68), a macrophage-
specifi c endosomal protein.  Biochem. J.  338 :  687 – 694 . 
  6 .  O’Reilly ,  D. ,  C. M.  Quinn ,  T.  El-Shanawany ,  S.  Gordon , and  D. R. 
 Greaves .  2003 .  Multiple Ets factors and interferon regulatory fac-
tor-4 modulate CD68 expression in a cell type-specifi c manner.  J. 
Biol. Chem.  278 :  21909 – 21919 . 
  7 .  Gough ,  P. J. , and  E. W.  Raines .  2003 .  Gene therapy of apolipopro-
tein E-defi cient mice using a novel macrophage-specifi c retroviral 
vector.  Blood .  101 :  485 – 491 . 
  8 .  Pillai ,  M. M. ,  B.  Hayes , and  B.  Torok-Storb .  2009 . Inducible 
transgenes under the control of the hCD68 promoter identifi es 
mouse macrophages with a distribution that differs from the 
F4/80- and CSF-1R-expressing populations.  Exp. Hematol .  37: 
1387–1392. 
  9 .  Pan ,  H. ,  G.  Mostoslavsky ,  E.  Eruslanov ,  D. N.  Kotton , and  I.  Kramnik . 
 2008 .  Dual-promoter lentiviral system allows inducible expression 
of noxious proteins in macrophages.  J. Immunol. Methods .  329 : 
 31 – 44 . 
 10 .  Ramprasad ,  M. P. ,  W.  Fischer ,  J. L.  Witztum ,  G. R.  Sambrano ,  O. 
 Quehenberger , and  D.  Steinberg .  1995 .  The 94- to 97-kDa mouse 
macrophage membrane protein that recognizes oxidized low den-
sity lipoprotein and phosphatidylserine-rich liposomes is identical 
to macrosialin, the mouse homologue of human CD68.  Proc. Natl. 
Acad. Sci. USA .  92 :  9580 – 9584 . 
 11 .  Murphy ,  J. E. ,  P. R.  Tedbury ,  S.  Homer-Vanniasinkam ,  J. H.  Walker , 
and  S.  Ponnambalam .  2005 .  Biochemistry and cell biology of mam-
malian scavenger receptors.  Atherosclerosis .  182 :  1 – 15 . 
 12 .  Kurushima ,  H. ,  M.  Ramprasad ,  N.  Kondratenko ,  D. M.  Foster ,  O. 
 Quehenberger , and  D.  Steinberg .  2000 .  Surface expression and 
rapid internalization of macrosialin (mouse CD68) on elicited 
mouse peritoneal macrophages.  J. Leukoc. Biol.  67 :  104 – 108 . 
 13 .  Sambrano ,  G. R. , and  D.  Steinberg .  1995 .  Recognition of oxidatively 
damaged and apoptotic cells by an oxidized low density lipoprotein 
receptor on mouse peritoneal macrophages: role of membrane 
phosphatidylserine.  Proc. Natl. Acad. Sci. USA .  92 :  1396 – 1400 . 
 14 .  de Beer ,  M. C. ,  Z.  Zhao ,  N. R.  Webb ,  D. R.  van der Westhuyzen , 
and  W. J.  de Villiers .  2003 .  Lack of a direct role for macrosialin in 
oxidized LDL metabolism.  J. Lipid Res.  44 :  674 – 685 . 
 15 .  Malleret ,  G. ,  U.  Haditsch ,  D.  Genoux ,  M. W.  Jones ,  T. V.  Bliss ,  A. 
M.  Vanhoose ,  C.  Weitlauf ,  E. R.  Kandel ,  D. G.  Winder , and  I. M. 
 Mansuy .  2001 .  Inducible and reversible enhancement of learning, 
memory, and long-term potentiation by genetic inhibition of cal-
cineurin.  Cell .  104 :  675 – 686 . 
 16 .  Srinivas ,  S. ,  T.  Watanabe ,  C. S.  Lin ,  C. M.  William ,  Y.  Tanabe ,  T. M. 
 Jessell , and  F.  Costantini .  2001 .  Cre reporter strains produced by 
targeted insertion of  EYFP and  ECFP into the  ROSA26 locus.  BMC 
Dev. Biol.  1 :  4 . 
 17 .  Nagy ,  A. ,  J.  Rossant ,  R.  Nagy ,  W.  Abramow-Newerly , and  J. C. 
 Roder .  1993 .  Derivation of completely cell culture-derived mice 
from early-passage embryonic stem cells.  Proc. Natl. Acad. Sci. USA . 
 90 :  8424 – 8428 . 
 18 .  Park ,  C. ,  S.  Li ,  E.  Cha , and  C.  Schindler .  2000 .  Immune response in 
Stat2 knockout mice.  Immunity .  13 :  795 – 804 . 
 19 .  Zhao ,  W. ,  E. N.  Cha ,  C.  Lee ,  C. Y.  Park , and  C.  Schindler .  2007 . 
 Stat2-dependent regulation of MHC class II expression.  J. Immunol. 
 179 :  463 – 471 . 
 20 .  Melillo ,  J. A. ,  L.  Song ,  G.  Bhagat ,  A. B.  Blazquez ,  C. R.  Plumlee , 
 C.  Lee ,  C.  Berin ,  B.  Reizis , and  C.  Schindler .  2010 .  Dendritic cell 
(DC)-specifi c targeting reveals Stat3 as a negative regulator of DC 
function.  J. Immunol.  184 :  2638 – 2645 . 
 21 .  Chang ,  D. H. ,  C.  Angelin-Duclos , and  K.  Calame .  2000 .  BLIMP-1: 
trigger for differentiation of myeloid lineage.  Nat. Immunol.  1 : 
 169 – 176 . 
 22 .  Hendriks ,  W. L. ,  H.  van der Boom ,  L. C.  van Vark , and  L. M. 
 Havekes .  1996 .  Lipoprotein lipase stimulates the binding and up-
take of moderately oxidized low-density lipoprotein by J774 mac-
rophages.  Biochem. J.  314 :  563 – 568 . 
 23 .  Song ,  L. , and  C.  Schindler .  2004 .  IL-6 and the acute phase response 
in murine atherosclerosis.  Atherosclerosis .  177 :  43 – 51 . 
 S. aureus ( Fig. 3B ). Likewise, CD68   /   macrophages (see 
 Fig. 4 ) and mice (data not shown) exhibited a normal in-
nate response to infection with bacterial pathogens (e.g., 
 S. aureus and  L. monocytogenes; data not shown) and VSV. 
These observations are consistent with the possibility that 
CD68 may play a redundant role in phagosome-lysosome 
fusion, as has recently been reported in LAMP-1/LAMP-2 
double-knockout murine embryonic fi broblasts (MEFS) 
( 41 ). This potentially redundant role will be explored in 
future studies. 
 Next, we considered the possibility that CD68 might 
regulate other aspects of the immune response. First, the 
ability of a few signature PAMPs and DAMPs to stimulate 
an infl ammatory response in either macrophages or DCs 
was evaluated. Again, the loss of CD68 was not associated 
with any defect in cytokine production ( Fig. 5 ), but there 
was a trend toward modestly enhanced DC activation (i.e., 
cell surface CD86 and MHC-II expression) in CD68   /   
mononuclear phagocytes. Consistent with a potential role 
in regulating the ability of these cells to present antigens, 
OVA-loaded CD68   /   DCs were found to be more effec-
tive in stimulating the proliferation of OVA-MHC-II-spe-
cifi c, OT-II T-cells, especially at higher doses of this antigen 
( Fig. 6 ). The equally enhanced capacity of CD68   /   DCs 
to present ovalbumin peptide to OT-II T-cells suggests that 
CD68 is not likely to regulate antigen processing but, 
rather, MHC-II loading or transport or both to the cell 
surface. Intriguingly, LAMP-1 and LAMP-2 may regulate 
Rab7-dependent phago-lysosomal interactions and traf-
fi cking ( 41 ). Moreover, LAMP-2 has been implicated in 
the “retrograde” movement of MHC-II molecules from a 
late-endosome/lysosome-like, multivesicular body, where 
they are stored and loaded with antigen into CD68-positive 
tubular structures, from which antigen-loaded MHC-II 
vesicles appear to bud on their way to the cell surface ( 42, 
43 ). Consistent with the possibility that CD68 may nega-
tively regulate this process, basal MHC-II surface expres-
sion was enhanced in CD68   /   DCs. However, this 
enhanced capacity to present antigens in vitro was not as-
sociated with a proclivity toward autoimmunity (aged 
CD68   /   mice remained healthy) or an overly exuberant 
innate response to bacterial infection. Future studies will 
need to more rigorously evaluate the potential role CD68 
plays in regulating the complicated movement of MHC-II 
molecules from multivesicular bodies, where they are anti-
gen-loaded, to the cell surface, where they present anti-
gen. This investigation will include exploring whether loss 
of CD68 is associated with changes in either the quantity 
or quality of adaptive T-cell-dependent responses, as well 
as humoral immunity during controlled immune chal-
lenges.  
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